APO Research
Talk to an analyst

APO RESEARCH · REPORT

Guillain-Barre Syndrome Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Guillain-Barre Syndrome Drugs Industry Growth and Trends Forecast to 2032

19 December 202590 pages

Choose your research edition.

Industry ResearchGuillain-Barre Syndrome Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Guillain-Barre Syndrome Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Guillain-Barre Syndrome Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Guillain-Barre Syndrome Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Guillain-Barre Syndrome Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Guillain-Barre Syndrome Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Guillain-Barre Syndrome Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Guillain-Barre Syndrome Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Guillain-Barre Syndrome Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Guillain-Barre Syndrome Drugs include Vitality Biopharma Inc, Regenesance BV, Hansa Medical AB, CuraVac Inc, Annexon Inc and Akari Therapeutics Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Guillain-Barre Syndrome Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Guillain-Barre Syndrome Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Guillain-Barre Syndrome Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Guillain-Barre Syndrome Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Guillain-Barre Syndrome Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Guillain-Barre Syndrome Drugs Market by Company

Vitality Biopharma Inc

Regenesance BV

Hansa Medical AB

CuraVac Inc

Annexon Inc

Akari Therapeutics Plc

Guillain-Barre Syndrome Drugs Segment by Type

Coversin

Immune Globulin

Others

Guillain-Barre Syndrome Drugs Segment by Application

Clinic

Hospital

Others

Guillain-Barre Syndrome Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Guillain-Barre Syndrome Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Guillain-Barre Syndrome Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Guillain-Barre Syndrome Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Guillain-Barre Syndrome Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Guillain-Barre Syndrome Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Coversin Table 2. Major Company of Immune Globulin Table 3. Major Company of Others Table 4. Global Guillain-Barre Syndrome Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Guillain-Barre Syndrome Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Guillain-Barre Syndrome Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Guillain-Barre Syndrome Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Guillain-Barre Syndrome Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Guillain-Barre Syndrome Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Guillain-Barre Syndrome Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Guillain-Barre Syndrome Drugs Industry Trends Table 26. Guillain-Barre Syndrome Drugs Industry Drivers Table 27. Guillain-Barre Syndrome Drugs Industry Opportunities and Challenges Table 28. Guillain-Barre Syndrome Drugs Industry Restraints Table 29. Global Guillain-Barre Syndrome Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Guillain-Barre Syndrome Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Guillain-Barre Syndrome Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Guillain-Barre Syndrome Drugs Sales Share by Company (2021-2026) Table 33. Global Guillain-Barre Syndrome Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Guillain-Barre Syndrome Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Guillain-Barre Syndrome Drugs Major Company Production Sites and Headquarters Table 36. Global Guillain-Barre Syndrome Drugs Company, Product Type & Application Table 37. Global Guillain-Barre Syndrome Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Guillain-Barre Syndrome Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Guillain-Barre Syndrome Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Guillain-Barre Syndrome Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Guillain-Barre Syndrome Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Guillain-Barre Syndrome Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Guillain-Barre Syndrome Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Guillain-Barre Syndrome Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Guillain-Barre Syndrome Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Guillain-Barre Syndrome Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Guillain-Barre Syndrome Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Guillain-Barre Syndrome Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Guillain-Barre Syndrome Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Guillain-Barre Syndrome Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Guillain-Barre Syndrome Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Guillain-Barre Syndrome Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Guillain-Barre Syndrome Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Guillain-Barre Syndrome Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Vitality Biopharma Inc Company Information Table 73. Vitality Biopharma Inc Business Overview Table 74. Vitality Biopharma Inc Guillain-Barre Syndrome Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Vitality Biopharma Inc Guillain-Barre Syndrome Drugs Product Portfolio Table 76. Vitality Biopharma Inc Recent Development Table 77. Regenesance BV Company Information Table 78. Regenesance BV Business Overview Table 79. Regenesance BV Guillain-Barre Syndrome Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Regenesance BV Guillain-Barre Syndrome Drugs Product Portfolio Table 81. Regenesance BV Recent Development Table 82. Hansa Medical AB Company Information Table 83. Hansa Medical AB Business Overview Table 84. Hansa Medical AB Guillain-Barre Syndrome Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hansa Medical AB Guillain-Barre Syndrome Drugs Product Portfolio Table 86. Hansa Medical AB Recent Development Table 87. CuraVac Inc Company Information Table 88. CuraVac Inc Business Overview Table 89. CuraVac Inc Guillain-Barre Syndrome Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. CuraVac Inc Guillain-Barre Syndrome Drugs Product Portfolio Table 91. CuraVac Inc Recent Development Table 92. Annexon Inc Company Information Table 93. Annexon Inc Business Overview Table 94. Annexon Inc Guillain-Barre Syndrome Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Annexon Inc Guillain-Barre Syndrome Drugs Product Portfolio Table 96. Annexon Inc Recent Development Table 97. Akari Therapeutics Plc Company Information Table 98. Akari Therapeutics Plc Business Overview Table 99. Akari Therapeutics Plc Guillain-Barre Syndrome Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Akari Therapeutics Plc Guillain-Barre Syndrome Drugs Product Portfolio Table 101. Akari Therapeutics Plc Recent Development Table 102. North America Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. North America Guillain-Barre Syndrome Drugs Sales by Country (2021-2026) & (K Units) Table 104. North America Guillain-Barre Syndrome Drugs Sales Market Share by Country (2021-2026) Table 105. North America Guillain-Barre Syndrome Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 106. North America Guillain-Barre Syndrome Drugs Sales Market Share Forecast by Country (2027-2032) Table 107. North America Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Guillain-Barre Syndrome Drugs Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Guillain-Barre Syndrome Drugs Market Share by Country (2021-2026) Table 110. North America Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Guillain-Barre Syndrome Drugs Market Share Forecast by Country (2027-2032) Table 112. Europe Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Europe Guillain-Barre Syndrome Drugs Sales by Country (2021-2026) & (K Units) Table 114. Europe Guillain-Barre Syndrome Drugs Sales Market Share by Country (2021-2026) Table 115. Europe Guillain-Barre Syndrome Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 116. Europe Guillain-Barre Syndrome Drugs Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Guillain-Barre Syndrome Drugs Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Guillain-Barre Syndrome Drugs Market Share by Country (2021-2026) Table 120. Europe Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Guillain-Barre Syndrome Drugs Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Guillain-Barre Syndrome Drugs Sales by Country (2021-2026) & (K Units) Table 124. Asia-Pacific Guillain-Barre Syndrome Drugs Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Guillain-Barre Syndrome Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 126. Asia-Pacific Guillain-Barre Syndrome Drugs Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Guillain-Barre Syndrome Drugs Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Guillain-Barre Syndrome Drugs Market Share by Country (2021-2026) Table 130. Asia-Pacific Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Guillain-Barre Syndrome Drugs Market Share Forecast by Country (2027-2032) Table 132. Latin America Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Latin America Guillain-Barre Syndrome Drugs Sales by Country (2021-2026) & (K Units) Table 134. Latin America Guillain-Barre Syndrome Drugs Sales Market Share by Country (2021-2026) Table 135. Latin America Guillain-Barre Syndrome Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 136. Latin America Guillain-Barre Syndrome Drugs Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Guillain-Barre Syndrome Drugs Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Guillain-Barre Syndrome Drugs Market Share by Country (2021-2026) Table 140. Latin America Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Guillain-Barre Syndrome Drugs Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 146. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Guillain-Barre Syndrome Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Guillain-Barre Syndrome Drugs Market Share by Country (2021-2026) Table 150. Middle East and Africa Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Guillain-Barre Syndrome Drugs Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Guillain-Barre Syndrome Drugs Distributors List Table 155. Guillain-Barre Syndrome Drugs Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Guillain-Barre Syndrome Drugs Image Figure 2. Global Guillain-Barre Syndrome Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Guillain-Barre Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Guillain-Barre Syndrome Drugs Sales (2021-2032) & (K Units) Figure 5. Coversin Image Figure 6. Global Coversin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Immune Globulin Image Figure 8. Global Immune Globulin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Guillain-Barre Syndrome Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Guillain-Barre Syndrome Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Guillain-Barre Syndrome Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Guillain-Barre Syndrome Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Guillain-Barre Syndrome Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Guillain-Barre Syndrome Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Guillain-Barre Syndrome Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Guillain-Barre Syndrome Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Guillain-Barre Syndrome Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Guillain-Barre Syndrome Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Guillain-Barre Syndrome Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Guillain-Barre Syndrome Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Guillain-Barre Syndrome Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Guillain-Barre Syndrome Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Guillain-Barre Syndrome Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Guillain-Barre Syndrome Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Guillain-Barre Syndrome Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Guillain-Barre Syndrome Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Guillain-Barre Syndrome Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Guillain-Barre Syndrome Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Guillain-Barre Syndrome Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Guillain-Barre Syndrome Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Guillain-Barre Syndrome Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Guillain-Barre Syndrome Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Guillain-Barre Syndrome Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Guillain-Barre Syndrome Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Guillain-Barre Syndrome Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Guillain-Barre Syndrome Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Guillain-Barre Syndrome Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Guillain-Barre Syndrome Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Guillain-Barre Syndrome Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Guillain-Barre Syndrome Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Guillain-Barre Syndrome Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Coversin
  • Immune Globulin
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Vitality Biopharma Inc
  • Regenesance BV
  • Hansa Medical AB
  • CuraVac Inc
  • Annexon Inc
  • Akari Therapeutics Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Guillain-Barre Syndrome Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Guillain-Barre Syndrome Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Guillain-Barre Syndrome Drugs Market by Type
  6. 1.3.1 Coversin
  7. 1.3.2 Immune Globulin
  8. 1.3.3 Others
  9. 1.4 Global Guillain-Barre Syndrome Drugs Market Size by Type
  10. 1.4.1 Global Guillain-Barre Syndrome Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Guillain-Barre Syndrome Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Guillain-Barre Syndrome Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Guillain-Barre Syndrome Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Guillain-Barre Syndrome Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Guillain-Barre Syndrome Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Guillain-Barre Syndrome Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Guillain-Barre Syndrome Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Guillain-Barre Syndrome Drugs Industry Trends
  2. 2.2 Guillain-Barre Syndrome Drugs Industry Drivers
  3. 2.3 Guillain-Barre Syndrome Drugs Industry Opportunities and Challenges
  4. 2.4 Guillain-Barre Syndrome Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Guillain-Barre Syndrome Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Guillain-Barre Syndrome Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Guillain-Barre Syndrome Drugs Price (2021-2026)
  4. 3.4 Global Guillain-Barre Syndrome Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Guillain-Barre Syndrome Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Guillain-Barre Syndrome Drugs Company, Product Type & Application
  7. 3.7 Global Guillain-Barre Syndrome Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Guillain-Barre Syndrome Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Guillain-Barre Syndrome Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Guillain-Barre Syndrome Drugs Tier 1, Tier 2, and Tier 3
4 Guillain-Barre Syndrome Drugs Regional Status and Outlook
  1. 4.1 Global Guillain-Barre Syndrome Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Guillain-Barre Syndrome Drugs Historic Market Size by Region
  3. 4.2.1 Global Guillain-Barre Syndrome Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Guillain-Barre Syndrome Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Guillain-Barre Syndrome Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Guillain-Barre Syndrome Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Guillain-Barre Syndrome Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Guillain-Barre Syndrome Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Guillain-Barre Syndrome Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Guillain-Barre Syndrome Drugs by Application
  1. 5.1 Guillain-Barre Syndrome Drugs Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Guillain-Barre Syndrome Drugs Market Size by Application
  6. 5.2.1 Global Guillain-Barre Syndrome Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Guillain-Barre Syndrome Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Guillain-Barre Syndrome Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Guillain-Barre Syndrome Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Guillain-Barre Syndrome Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Guillain-Barre Syndrome Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Guillain-Barre Syndrome Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Guillain-Barre Syndrome Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Vitality Biopharma Inc
  2. 6.1.1 Vitality Biopharma Inc Company Information
  3. 6.1.2 Vitality Biopharma Inc Business Overview
  4. 6.1.3 Vitality Biopharma Inc Guillain-Barre Syndrome Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Vitality Biopharma Inc Guillain-Barre Syndrome Drugs Product Portfolio
  6. 6.1.5 Vitality Biopharma Inc Recent Developments
  7. 6.2 Regenesance BV
  8. 6.2.1 Regenesance BV Company Information
  9. 6.2.2 Regenesance BV Business Overview
  10. 6.2.3 Regenesance BV Guillain-Barre Syndrome Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Regenesance BV Guillain-Barre Syndrome Drugs Product Portfolio
  12. 6.2.5 Regenesance BV Recent Developments
  13. 6.3 Hansa Medical AB
  14. 6.3.1 Hansa Medical AB Company Information
  15. 6.3.2 Hansa Medical AB Business Overview
  16. 6.3.3 Hansa Medical AB Guillain-Barre Syndrome Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hansa Medical AB Guillain-Barre Syndrome Drugs Product Portfolio
  18. 6.3.5 Hansa Medical AB Recent Developments
  19. 6.4 CuraVac Inc
  20. 6.4.1 CuraVac Inc Company Information
  21. 6.4.2 CuraVac Inc Business Overview
  22. 6.4.3 CuraVac Inc Guillain-Barre Syndrome Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CuraVac Inc Guillain-Barre Syndrome Drugs Product Portfolio
  24. 6.4.5 CuraVac Inc Recent Developments
  25. 6.5 Annexon Inc
  26. 6.5.1 Annexon Inc Company Information
  27. 6.5.2 Annexon Inc Business Overview
  28. 6.5.3 Annexon Inc Guillain-Barre Syndrome Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Annexon Inc Guillain-Barre Syndrome Drugs Product Portfolio
  30. 6.5.5 Annexon Inc Recent Developments
  31. 6.6 Akari Therapeutics Plc
  32. 6.6.1 Akari Therapeutics Plc Company Information
  33. 6.6.2 Akari Therapeutics Plc Business Overview
  34. 6.6.3 Akari Therapeutics Plc Guillain-Barre Syndrome Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Akari Therapeutics Plc Guillain-Barre Syndrome Drugs Product Portfolio
  36. 6.6.5 Akari Therapeutics Plc Recent Developments
7 North America by Country
  1. 7.1 North America Guillain-Barre Syndrome Drugs Sales by Country
  2. 7.1.1 North America Guillain-Barre Syndrome Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Guillain-Barre Syndrome Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Guillain-Barre Syndrome Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Guillain-Barre Syndrome Drugs Market Size by Country
  6. 7.2.1 North America Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Guillain-Barre Syndrome Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Guillain-Barre Syndrome Drugs Sales by Country
  2. 8.1.1 Europe Guillain-Barre Syndrome Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Guillain-Barre Syndrome Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Guillain-Barre Syndrome Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Guillain-Barre Syndrome Drugs Market Size by Country
  6. 8.2.1 Europe Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Guillain-Barre Syndrome Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Guillain-Barre Syndrome Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Guillain-Barre Syndrome Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Guillain-Barre Syndrome Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Guillain-Barre Syndrome Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Guillain-Barre Syndrome Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Guillain-Barre Syndrome Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Guillain-Barre Syndrome Drugs Sales by Country
  2. 10.1.1 South America Guillain-Barre Syndrome Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Guillain-Barre Syndrome Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Guillain-Barre Syndrome Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Guillain-Barre Syndrome Drugs Market Size by Country
  6. 10.2.1 South America Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Guillain-Barre Syndrome Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Guillain-Barre Syndrome Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Guillain-Barre Syndrome Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Guillain-Barre Syndrome Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Guillain-Barre Syndrome Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Guillain-Barre Syndrome Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Guillain-Barre Syndrome Drugs Value Chain Analysis
  2. 12.1.1 Guillain-Barre Syndrome Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Guillain-Barre Syndrome Drugs Production Mode & Process
  7. 12.2 Guillain-Barre Syndrome Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Guillain-Barre Syndrome Drugs Distributors
  10. 12.2.3 Guillain-Barre Syndrome Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst